Literature DB >> 2961491

Activated neutrophils exhibit enhanced phagocytosis of Cryptococcus neoformans opsonized with normal human serum.

T R Kozel1, G S Pfrommer, D Redelman.   

Abstract

We studied the effect of agents that activate neutrophils on phagocytosis of C. neoformans. The amount of CR3 on the surface of neutrophils was used as a marker for neutrophil activation. Surface CR3 was estimated by flow cytometry using phycoerythrin-labelled anti-CR3 (anti-Leu-15) monoclonal antibody. Phagocytosis was determined by incubation of neutrophils with cryptococci that had been preincubated with normal human serum. We found that treatment of neutrophils with (i) the chemotactic peptide N-formyl-methionyl-leucyl-phenylalanine, (ii) zymosan activated serum, (iii) supernatant fluid from a mixed leucocyte culture, or (iv) supernatant fluid from human leucocytes cultured with phytohaemagglutinin produced a dose-dependent increase in CR3 density. These agents also markedly enhanced phagocytosis of opsonized cryptococci in a parallel dose-dependent fashion. These results indicate that phagocytosis of cryptococci opsonized with normal human serum is markedly enhanced by treatment of neutrophils with reagents that stimulate neutrophils. Our results demonstrate that neutrophils activated in an appropriate manner are capable of efficient phagocytosis of encapsulated cryptococci. This potential phagocyte activity may account in part for the high natural resistance to cryptococcosis.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2961491      PMCID: PMC1542204     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  20 in total

1.  The role of the classical and alternate complement pathways in host defenses against Cryptococcus neoformans infection.

Authors:  R D Diamond; J E May; M A Kane; M M Frank; J E Bennett
Journal:  J Immunol       Date:  1974-06       Impact factor: 5.422

2.  Factors influencing killing of Cryptococcus neoformans by human leukocytes in vitro.

Authors:  R D Diamond; R K Root; J E Bennett
Journal:  J Infect Dis       Date:  1972-04       Impact factor: 5.226

3.  Single-step separation of red blood cells. Granulocytes and mononuclear leukocytes on discontinuous density gradients of Ficoll-Hypaque.

Authors:  D English; B R Andersen
Journal:  J Immunol Methods       Date:  1974-08       Impact factor: 2.303

4.  Prognostic factors in cryptococcal meningitis. A study in 111 cases.

Authors:  R D Diamond; J E Bennett
Journal:  Ann Intern Med       Date:  1974-02       Impact factor: 25.391

5.  Leucoattractants enhance complement receptors on human phagocytic cells.

Authors:  A B Kay; E J Glass; D M Salter
Journal:  Clin Exp Immunol       Date:  1979-11       Impact factor: 4.330

6.  Inhibition of phagocytosis by cryptococcal polysaccharide: dissociation of the attachment and ingestion phases of phagocytosis.

Authors:  T R Kozel; R P Mastroianni
Journal:  Infect Immun       Date:  1976-07       Impact factor: 3.441

7.  Opsonic requirements for the uptake of Cryptococcus neoformans by human polymorphonuclear leukocytes and monocytes.

Authors:  S F Davies; D P Clifford; J R Hoidal; J E Repine
Journal:  J Infect Dis       Date:  1982-06       Impact factor: 5.226

8.  Cryptococcus neoformans. II. Phagocytosis by human leukocytes.

Authors:  G S Bulmer; M D Sans
Journal:  J Bacteriol       Date:  1967-11       Impact factor: 3.490

9.  Opsonization of Cryptococcus neoformans by human immunoglobulin G: masking of immunoglobulin G by cryptococcal polysaccharide.

Authors:  T G McGaw; T R Kozel
Journal:  Infect Immun       Date:  1979-07       Impact factor: 3.441

10.  Degranulation, membrane addition, and shape change during chemotactic factor-induced aggregation of human neutrophils.

Authors:  S T Hoffstein; R S Friedman; G Weissmann
Journal:  J Cell Biol       Date:  1982-10       Impact factor: 10.539

View more
  14 in total

Review 1.  Host-parasite interaction in fungal infections.

Authors:  N Khardori
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-04       Impact factor: 3.267

Review 2.  Immunological aspects of fungal pathogenesis.

Authors:  G S Deepe; W E Bullock
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-08       Impact factor: 3.267

Review 3.  Host immunity to Cryptococcus neoformans.

Authors:  Soma Rohatgi; Liise-Anne Pirofski
Journal:  Future Microbiol       Date:  2015       Impact factor: 3.165

4.  Antifungal activity of a human antiglucuronoxylomannan antibody.

Authors:  Z Zhong; L A Pirofski
Journal:  Clin Diagn Lab Immunol       Date:  1998-01

5.  Encapsulation of Cryptococcus neoformans with glucuronoxylomannan inhibits the antigen-presenting capacity of monocytes.

Authors:  C Retini; A Vecchiarelli; C Monari; F Bistoni; T R Kozel
Journal:  Infect Immun       Date:  1998-02       Impact factor: 3.441

6.  Biomolecular events involved in anticryptococcal resistance in the brain.

Authors:  E Blasi; R Barluzzi; R Mazzolla; L Pitzurra; M Puliti; S Saleppico; F Bistoni
Journal:  Infect Immun       Date:  1995-04       Impact factor: 3.441

7.  Killing of Cryptococcus neoformans strains by human neutrophils and monocytes.

Authors:  M F Miller; T G Mitchell
Journal:  Infect Immun       Date:  1991-01       Impact factor: 3.441

8.  Experimental model of intracerebral infection with Cryptococcus neoformans: roles of phagocytes and opsonization.

Authors:  E Blasi; R Barluzzi; R Mazzolla; P Mosci; F Bistoni
Journal:  Infect Immun       Date:  1992-09       Impact factor: 3.441

9.  Encapsulation of Cryptococcus neoformans regulates fungicidal activity and the antigen presentation process in human alveolar macrophages.

Authors:  A Vecchiarelli; D Pietrella; M Dottorini; C Monari; C Retini; T Todisco; F Bistoni
Journal:  Clin Exp Immunol       Date:  1994-11       Impact factor: 4.330

10.  Real-Time Imaging of Interactions of Neutrophils with Cryptococcus neoformans Demonstrates a Crucial Role of Complement C5a-C5aR Signaling.

Authors:  Donglei Sun; Mingshun Zhang; Gongguan Liu; Hui Wu; Xiaoping Zhu; Hong Zhou; Meiqing Shi
Journal:  Infect Immun       Date:  2015-10-26       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.